Q Wang Research Lab Cedars Sinai
Q. Wang Research Lab Cedars-Sinai Skip to content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog English English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Translation is unavailable for Internet Explorer Cedars-Sinai Home 1-800-CEDARS-1 1-800-CEDARS-1 Close Find a Doctor Locations Programs & Services Health Library Patient & Visitors Community My CS-Link RESEARCH clear Go Close Navigation Links Academics Faculty Development Community Engagement Calendar Research Research Areas Research Labs Departments & Institutes Find Clinical Trials Research Cores Research Administration Basic Science Research Clinical & Translational Research Center (CTRC) Technology & Innovations News & Breakthroughs Education Graduate Medical Education Continuing Medical Education Graduate School of Biomedical Sciences Professional Training Programs Medical Students Campus Life Office of the Dean Simulation Center Medical Library Program in the History of Medicine About Us All Education Programs Departments & Institutes Faculty Directory Q Wang Lab Welcome to Wang Laboratory, led by Qiang Wang, PhD, at the Cedars-Sinai Department of Medicine, Gastroenterology/Hepatology Research Program and Pancreatic Research Program. The Wang Lab studies the signals that control cell growth and division and how deregulation of these signals may contribute to the development of human cancers. Current areas of research include metastasis, tissue regeneration and repair, inflammation and microenvironment, cancer resistance to therapeutics and biomarkers for diagnosis and prognosis of human cancer. A major interest of the Wang Laboratory is to validate and develop novel targeted therapy for cancer. The Wang Laboratory is affiliated with the Gastroenterology/Hepatology Research Program, Pancreatic Research Program, Department of Medicine and Samuel Oschin Comprehensive Cancer Institute. Breakthrough Research Areas Molecular Basis of Cancer Progression and Metastasis Pancreatic Tissue Regeneration and Alcoholic Pancreatitis Cancer Drug Resistance and Targeted Therapy Cell Cycle Regulation Collaborations & Research Techniques Collaborations Bhowmick Laboratory Lu Laboratory Samuel Oschin Comprehensive Cancer Institute Pandol Laboratory Pancreatic Research Program Seki Laboratory Research Techniques In vivo and in vitro models of tumorigenesis Mouse models of pancreatitis and pancreatic regeneration Retro/lenti/adeno-viral transduction cDNA cloning qPCR Recombinant protein production and purification Biochemistry Flow cytometry and cell sorting Microscopy Knockout and RNAi technology ChIP-Seq and global transcription analysis Proteomics and mass spectrometry Antibody development Immunohistochemistry and immnunofluorescence Meet Our Team Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Q Wang Laboratory, whose dedicated efforts lead to groundbreaking discoveries. View Our Team Publications Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Morvaridi S, Dhall D, Greene MI, Pandol SJ, Wang Q. Sci. Rep. 2015;5:16759. FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer. Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, Zhang X, Li N, Bose S, Wang Q, et al. Cell Rep. 2015;13(5):1046-1058. Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS. Taylor-Harding B, Aspuria PJ, Agadjanian H, Cheon DJ, Mizuno T, Greenberg D, Allen JR, Spurka L, Funari V, Spiteri E, Wang Q, et al. Oncotarget. 2015 Jan 20;6(2):696-714. Contact the Q Wang Lab 8700 Beverly Blvd. Davis Building, Room 3098 Los Angeles, California 90048 310-423-7638 Fax: 310-248-6799 Send A Message Please ensure Javascript is enabled for purposes of website accessibility